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Phosphatidylinositol 3kinase (PI-3 kinase) actwity has been linked to cell proliferation and growth regulation. Therefore, we studied changes m 
phosphoinositide metabolism during the cell cycle of HT-29 cells. a colonic epithelial cell line HT29 cells were treated with the mtcrotubule dtsrupter, 
nocodozole, separated mto mitotic and quiescent populations and then phospholiptd composition was analyzed. Radtolabelled phospholipids from 
cells labelled with “PO, or [‘Hlmyoinositol were analyzed by TLC and/or deacylated and analyzed by HPLC. In all cases. levels of phosphatidyl- 
mositol 3 phosphate from mttotic phase cells were double that in resting populattons. Therefore, levels of a product of PI-3 kinase are elevated 
and may play a role in cell division. 
PI-3 kinase; Phosphatidylinositol 3 phosphate: Colomc epttheha; Cell cycle 
1. INTRODUCTION 
Evidence is mounting for a role for phosphoinosi- 
tides, particularly novel phosphoinositides phosphor- 
ylated on the D-3 position of the inositol ring. in 
growth control. Inositol, a precursor for phosphoinosi- 
tides, is a nutrient which is essential for cell prolifera- 
tion. Two enzymes involved in phosphoinositide me- 
tabolism, phospholipase C (PLC) and phosphatidyl- 
inositol-3 kinase (PI-3 kinase), contain src homology 
(SH-2) domains which permit association with growth 
factor receptors possessing intrinsic tyrosine kinase ac- 
tivity. In accordance with this, D-3 phosphorylated 
phosphoinositides become transiently elevated in cells 
which have been exposed to these growth factors [l-6]. 
Furthermore, PI-3 kinase appears to play a role in 
transformation by the middle T antigen [7]. 
There is reason to suspect that PI-3 kinase activity 
may be altered in mitotic phase cells. Tyrosine phospho- 
rylation of PI-3 kinase promotes its association with 
SH-2 domains of pp60”” and growth factor receptors 
and thereby with the plasma membrane (for review see 
[7]). PI-3 kinase has been shown to be elevated in cells 
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Abbrewations. PLC, phospholipase C; PI(3)P. phosphatidylmosttol 3 
phosphate: PI(4)P. phosphatidylmosttol 4 phosphate; PI-3 kmase, 
phosphatidyhnositol-3 kinase; PIP. phosphatidylinositol phosphate. 
P1(3,4)P,. phosphatidylinositol 3,4 bisphosphate; PI(3,4,5)P,, 
phosphatidylinositol3.4,5 trtsphosphate; HEPES. 4-(2_hydroxyethyl)- 
1 -piperazme-ethanesulfonic acid; GroPI(3)P, glycerophosphoryhnost- 
to1 3 phosphate; GroPI(4)P. glycerophosphorylinositol 4 phosphate. 
with elevated src protein tyrosine kinase activity [8]. 
Recently, increased ~~60”” tyrosine kinase activity was 
observed during mitotis [9]. Human colon carcinoma 
cell lines, including HT29 have elevated pp60’“‘” activity 
relative to normal colonic mucosal cells [lo]. Therefore 
we were interested in investigating the occurrence of 
PI(3)P, PI(3,4)PZ and PI(3,4,5)P, in this cell line and 
their variance over the cell cycle. 
Here, we demonstrate that levels of [3’P]PI(3)P are 
elevated during the G,/M phase of the cell cycle. How- 
ever, there were no detectable changes in two other 
known products of PI-3 kinase, PI(3,4)Pz or PI(3,4,5)P,. 
2. MATERIALS AND METHODS 
2.1. A4utrtxds 
Nocodozole (methyl-(5-(2-thienyIcarbonyl)-lH-benzimidazol-2-yl)- 
carbamate) was purchased from Sigma Chemical Company, St. LOUIS. 
MO; DMEIF-12 (1: 1) from JRH Btosctence, Irvine, CA; y-“PO, was 
obtained from New England Nuclear and [‘Hlmyoinositol was ob- 
tamed from American Radiochemical (ARC). [“P]PI(3)P was gener- 
ously donated by Dr. Philhp Majerus. Washington Umv.. St. Louis. 
2 2. Cell culture 
HT29 cells were obtained from ATCC (Accession no. 
HTB38 F5451) Passages 1640 were used during these experiments. 
They were grown m a 1.1 mixture of Dulbecco-Vogt modified Eagle’s 
(DME) and Ham’s F-12 medtum, containing 5% newborn calf serum 
(Hyclone). supplemented with 15 mM HEPES buffer, pH 7.5. I-glu- 
tamme, 40 mg/l penictllm. 8 mg/l amptcilhn, and 90 mgll streptomycin. 
Cells were passaged every 4 days by splittmg at a ratio of 1:4 using 
trypsm/EDTA and grown in 100 mm tissue culture dishes (Costar. 
Cambridge, MA) in a humidified atmosphere of 5% COZ. 95% air. 
2.3 Segregclrron qf‘ G,,lG, wzd G,IM phase cells 
Cells were detached by trypsimzation with 0 1% trypsin and 0.9 mM 
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EDTA m Ca”- and Mg”-free phosphate-buffered sahne and were 
seeded at a dcnslty of 10’ cells/5 ml in 3-cm dishes for 2-3 days. Cells 
were then treated with 5 PM nocodozole [I I] for 14 to 16 h. Mltotlc 
phase cells were gently detached by agitation on a shaker tray for 5 
mm in Rmgers solution or 0.5 mM EDTA (Group M). G-phase cells 
were more adherent and remained attached following agitation 
(Group GI In some experiments these cells were detached by mcuba- 
tlon for 15 min with 0.5 mM EDTA m phosphate buffered salme (pH 
7.4) before lipid extraction Nocodozole treated cells were compared 
with cells which were not treated with nocodozole and were freely 
cycling (Group C). HT29 cells were fixed m 70% ethanol and stained 
with 4,6-diamidmo-2-phenyhndole (DAPI) and DNA content per cell 
was evaluated usmg an Ortho cytofluorograph. The cell cycle compo- 
sItion of each group 1s presented in Table I. Viability. tested by Trypan 
blue exclusion. was similar for all groups (M: 96% -t 0.8; G: 
94.4% i 0.5: 96.2 f 1.7. means + SE M II = 4). 
Radiolabelhng of HT29 cells with “PO, was carried out in phos- 
phate-free HEPES buffer containing 30 mM HEPES. I10 mM NaCl, 
10 mM NaCl. IO mM KCI. 1 mM MgCIZ, 1.53 mM CaCI,. and 10 mM 
glucose. “PO, (New England Nuclear, 50 ,&1/m]) with or wlthout 5 
PM nocodozole for 3 h. Comcubatcd controls without “PO, were 
mcluded with each experiment to momtor the cell cycle composltion. 
Following labelling. cells m Group M were harvested in EDTA buffer 
as described above. Unless otherwise indicated, Ice-cold methanol was 
added to the cells remainmg on the dish (Group G), the dishes were 
sonicated on ice, the cell suspension m methanol was removed to test 
tubes where the hpld extraction proceeded as described below. 
Cells were labelled with [‘Hlmyomosltol by replacmg their growth 
media with 1 ml of mositol-free DMEM/Fl2 medium (1:l. v/v) supple- 
mented with dialyzed newborn calf serum (5% I and myo-[2-‘Hlmosltol 
(12.8 Ci/mmol. 50 flCl/ml) Cells were then Incubated for 24 h after 
which time another 1 ml of medium contammg dialyzed serum was 
added and followed by an additional 48 h Incubation (72 h total). 
Lipid extraction was performed as described elsewhere [12] Two 
TLC protocols were used. TLC System I was used to separate general 
classes of lipids and used silica gel 60 (EM Science) TLC plates unpreg- 
nated with potassium owalate. The developing solvents were chloro- 
form/acetone/methanol/acetic acid/water. 80~30~2623.14 (v/v). For 
resolution of Pl(3)P and PI(4)P we used a second TLC techmque (II) 
described by [13] where the TLC plates (alhca gel 60. EM Science) were 
preimpregnated with borate. We found that allowmg the plate to 
develop m the impregnation solution overnight rather than dIpping 
the plate in the solution leads to better resolution of PI(3)P and PI(3)P. 
Lipids were quantitatcd with an AMBIS beta scanner or by scraping 
the appropriate bands of sihca gel which were subJected to scintillation 
counting. 
Phosphohplds were also analyzed by deacylation followed by 
HPLC as described [12]. The aqueous products of deacylation were 
resuspended in water and inJected on HPLC (see below). Glycerophos- 
phorylinositol phosphates and inositol phosphates were resolved by 
anion-exchange HPLC as described [4] on a 4 6 x 250 mm Partlsll 10 
SAX column (Whatman. Clifton, NJ) The radioactlvity in the ettluent 
was continuously measured by a Beckman 171 dual channel radio- 
isotope detector (Beckman, San Ramon, CA). which performed auto- 
matic peak integration usmg Beckman System Gold program soft- 
ware Identification of the inosltol phosphates was based on com- 
parison of their elution times v&h those of authentic radlolabelled 
standards (New England Nuclear. Boston. MA). myo-[2-3H]inositol. 
o-[inositol-2-2H(N)]mositol I-phoshate, o-[mositol-2-‘H(N)]inosltol 
IP-bisphosphate. o-[inositol+“H(N)]inositol 1.3,4-tnsphosphate, and 
o-[inositol-2-‘H(N)]inositoi tetraklsphosphate. “P-1abelled glycero- 
phosphoinosltol standards were prepared from neutrophils as de- 
scribed previously [ 121 These included [“P]GroPIP,, [‘?P]GroPI- 
(3,4)P,. [“P]GroPI(J.S)P,, and [“P]GroPI(4)P. [‘H]GroP1(3)P was 
identified by its elutlon time relative to [“P]GroP1(3)P prepared from 
authentic [“P]P1(3lP provided by Dr. Phillip MaJerus, St, Louis, MO 
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3. RESULTS 
3.1. Iderztijicatiorl of PI(3)e PI(S,I)P, and PI(3,4,5)- 
P_< in HTY cells 
HT29 cell phospholipids were labelled with 
[“Hlmyoinositol, and extracted as described in section 
2. TLC bands containing phosphoinositides were 
scraped and deacylated. The radiolabelled prod- 
ucts were then detected using a HPLC equipped with a 
radioisotope detector. As can be seen in Fig. 1, 
putative [‘Hlglycerophosphorylinositol-3 phosphate 
(GroPI(3)P) prepared from [.7H]inositol-labelled HT29 
cells comigrated with [“P]GroPI( 3)P prepared from au- 
thentic [“P]PI(3)P provided by Dr. Phillip Majerus. 
This was true of [3H]PIP prepared from cells of groups 
M, C and G. 
GroPI(3,4)P, and GroPI(3,4,5)P, were also ob- 
served and identified by comparison to authentic 
[“P]GroPI(3,4)P, and [3’P]GroPI(3,4,5)P3 prepared 
from human neutrophils as described [12] (data not 
shown). However, the levels of the deacylated products 
of [3’P]P1(3,4)P, and [32P]PIP3 were less than 10% of that 
of [32P]PI(3)P and were therefore not always detectable. 
However, when detected there was no difference in the 
levels of PI(3,4)P, (M: [“‘P]P1(3,4)P, = 1.67% of total 
[“PIPIP,; G: [“‘P]P1(3,4)P, = 1.68% total [3”P]PIP2, 
means of ?I = 2). 
3.2. PI(3)P is elewted in cell populations enriched in 
dividing cells 
HT29 cells were radiolabelled with “P for three hours 
and then segregated into G,/M phase cells (M) and 
G,/G, phase cells (G or C) as described in section 2. The 
Table I 
PI(3)P is elevated m populations of HT29 cells containing a high 
proportion of mitotic phase cells 
Cell cycle compartment 
G, + G,, GI + M 
(% total cells) 
[=P]PI(3)P 
(% total [“PIPIP) 
C 80.8 * 1.97 12.8 2 1.39**** 7.95 + 2.65** *** 
G 40.95 f 5.91 30.76 t 4.81**** 8.9 ? 1.0x*** 
M 2.35 f 0.46 80.1 ? 7.51* 21.2 + 7 45** - -.
(n = 7) (n = 7) (n = 5) 
Cells were labelled with “PO, and segregated mto populations en- 
riched in the various cell cycle compartments as described in sectlon 
2. Coincubated cells were analyzed for cell cycle composition by flow 
cytometry as described in section 2. Data is presented as percent of 
total cells m group C. G, or M m the mdlcated compartment. “P- 
labelled phospholipids were extracted and subJected to TLC to sepa- 
rate the phosphomositide classes. Bands of slhca gel containing 
phosphomositides were scraped, the phosphohpids were deacylated 
and the deacylated products were resolved by HPLC Data is pre- 
sented as percent total cpm m PIP. All data IS presented as 
means + S.E M Statistical significance was estimated using the un- 
paired Student’s t-test. *P < 0.0001 M vs. C or G; **P < 0.0005 C vs. 
M, ***P < 0.001 G 1’s. M; ****P < 0.005 C vs. G. 
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Fig. 1. Putative [‘H]GroPI(3)P from [‘Hlmyoinosttol-labelled HT29 
cells comigrates with authentic [‘*P]GroPI(3)P. Phospholipids from 
HT29 cells labelled with [‘H]myomositol as described above were 
extracted and deacylated Authentic [32P]PI(3)P generously donated by 
Dr. Phillip Majerus was also deacylated and coinjected with the aque- 
ous products of deacylation of ‘H-labelled phospholipids from both 
nocodozole treated and untreated cells. Radioactivity was detected by 
a Beckman 171 flow-through detector equipped with a 1 ml liquid flow 
cell. This experiment was repeated 3 times with similar results. The 
standard comigrated with putative GroPI(3)P from each group of 
cells, M, G and C. 
cell cycle composition of the three groups is presented 
in Table I. Phosphoinositide levels in phospholipid ex- 
tracts were measured using two techniques: (1) TLC (II) 
using a technique which resolved PI(3)P and PI(4)P but 
poorly separated other phospholipids (Fig. 2) or (2) 
TLC (I) which resolved PI, PIP, PIP2 and PIP, but did 
not resolve PI(3)P and PI(4)P which were subsequently 
resolved by deacylation and HPLC. As can be seen in 
Table I and Fig. 2, levels of PI(3)P relative to PI(4)P 
doubled in populations of HT29 cells enriched in G,/M 
phase cells (Group M) compared to populations en- 
riched in G,,/G, phase cells (Group G), when the 
phospholipids were separated by TLC (II) or TLC (I) 
followed by HPLC. The composition of PIP from cells 
not treated with nocodozole (Group C). where the pro- 
portions of cells in the M phase was relatively low, was 
comparable to the nocodozole treated, GdG, enriched 
population. 
3.3. [‘H]PI(3)P is elevated relative to [3H]PI(4)P in 
mitotic phase cells 
The 3, 4 and 5 phosphates on polyphosphoinositides 
turn over more rapidly than the 1 phosphate or the 
phosphate in other phospholipids. As a result poly- 
phosphoinositides are the first phospholipids to be la- 
belled in cells loaded with 3’P04 and reach equilibrium 
within a few hours. In contrast, [3H]myoinositol be- 
comes slowly incorporated into phosphoinositides and 
takes days to reach equilibrium. Hence, [3H]myoinositol 
may label a somewhat different pool of phosphoinosi- 
tides than 32P. Therefore, we studied phosphoinositide 
levels in HT29 cells labelled with [3H]myoinositol. HT29 
cells were labelled with [3H]myoinositol for 3 days (50 
@Zi/ml) in inositol-free medium after which the cells 
were incubated with regular medium containing 
myoinositol and nocodozole (5 PM) for 14 h as de- 
scribed in section 2. Coincubated controls were sepa- 
rated as before and checked for cell cycle composition 
as described above. The inositol labelling procedure did 
not interfere with the subsequent generation of popula- 
tions of cells in which G? + M phase cells were enriched 
(79%). When the phospholipids were extracted from 
these cells, separated by TLC (I), scraped from the TLC 
plates, deacylated and subjected to HPLC, the results 
reflected the findings with the 3’P-labelled cells. PI(3)P 
accounted for over 20% of the radioactivity in PIP in 
group M whereas it accounted for approximately 9% of 
the radioactivity in PIP in group G. 
3.4. The elevation of PI(3)P is not a function of cell 
attachment 
We then considered the possibility that the difference 
in PIP between mitotic phase and nonmitotic phase 
populations might result from the fact that the mitotic 
phase cells were not attached to the substratum whereas 
the nonmitotic phase cells were still attached when the 
lipids were extracted. If this were the case the difference 
in levels of PI(3)P would correspond to the degree of cell 
substratum adhesion and not necessarily the phase of 
the cell cycle. We therefore examined the composition 
of PIP from GrjGl enriched cells which had been de- 
tached by incubation in an EDTA containing phos- 
phate buffer for 15 min prior to lipid extraction. The 
ratio of PI(3)P to PI(4)P was similar to that from cells 
which were attached (8.67 +_ 0.23%; n = 3; mean 
? S.E.M.). 
4. DISCUSSION 
Here we demonstrate that levels of PI(3)P are ele- 
vated in mitotic phase cells. This was the case whether 
the phospholipids were labelled with [3H]myoinositol or 
3’P04. Furthermore, this difference was not due to the 
differences in cell substratum adhesion between mitotic 
and nonmitotic cells. Labelling of another product of 
PI-3 kinase, PI(3,4)P2 was 10% of that in PI( 3)P and was 
not detected in every experiment. However, levels of 
PI(3,4)P2 did not appear to be elevated in mitotic phase 
cells. Although we do not know whether this elevation 
of PI(3)P occurs in other cell types during mitosis, Se- 
runian and co-workers [14] reported an elevation of D-3 
phosphorylated phosphoinositides in subconfluent 
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Fig. 2. Autoradtogram of TLC resolutton of [3zP]PI(3)P and PI(4)P. 
[“‘PlPhospholiptds from cells consisting of primarily G:IM(M) or G,/ 
G,(G) phase cells were resolved by TLC (II) as described by Walsh 
et al. [13] Radioactivity m phosphohptd bands was quantttated usmg 
an AMBIS beta scanner IAMBIS. San Diego). [‘2P]P1t3)P from ml- 
totic phase cells accounted for 1.075 * 0.095% of total [“Plphospho- 
lipid compared to 0.55 f 0 025% in G,JG, (Mean of 4 experi- 
ments f S.D.. II = 4, P < 0.005; Student’s r-test ) 
NIH3T3 cells. Because subconfluent cultures have a 
higher proportion of mitotic phase cells than confluent 
cultures these results suggest that the phenomenon we 
report here may be widespread. Differences in the rela- 
tive levels of PI( 3)P and PI(4)P during the cell cycle may 
have functional significance. Tsai and co-workers have 
demonstrated that PIP was among the phospholipids 
which inhibited guanosine triphosphatase activating 
protein (GAP) activity and bound GAP tightly enough 
to retain it on an affinity column [15J. In addition, 
phosphoinositides selectively bind profilin and gelsolin 
and may thereby regulate cytoskeletal assembly [16-l 81. 
Possible mechanisms which could account for the ele- 
vation of PI(3)P include changes in the activities of PI-3 
kinase. PI-3 phosphatase. or the transfer protein which 
transfers PI to the plasma membrane where it may be 
further phosphorylated. Further studies will be required 
to differentiate between these possibilities or to ascer- 
tain whether the levels of PI-3 kinase or the activity of 
the enzyme is elevated in dividing cells. It is interesting 
that only PI(3)P appears to be elevated in mitotic phase 
cells and not other products of PI-3 kinase. Because 
levels of PIP, and PI(3,4)P, are often transient, it may 
be that the experiments described here do not have ade- 
quate time resolution to detect elevation of these prod- 
ucts. Therefore PIP, and PI(3.4)P, levels may be ele- 
vated at a certain point in the Gz or M phase of the cell 
cycle but are hydrolyzed to PI(3)P which accumulates 
and is the only detectable product using our current 
protocol. On the other hand PI(3)P itself may have a 
function in dividing cells. In either case, these findings 
suggest that product(s) of PI-3 kinase are elevated and 
may play a role during cell division. 
Achno~~,/~,~l~~r)?f,~~/.\ We would hke to express our gratitude to Dr. 
Phillip MaJerus for generously providmg [“P]P1(3)P and to Dr. Kim 
Barrett for helpful. critical comments. We would also like to acknowl- 
edge Denms Young for expert techmcal assistance with Huorescence 
activated cell sortmg This study was supported by a grant from the 
NIH. 1ROIDK233tJ5. G. Dobos was partially funded by the Fresemus 
Foundation, Oberursel, Germany. 
REFERENCES 
[I] Wahl, M I.. Nishtbe. S, Suh. P., Phee. S.G and Carpenter, G. 
(1989) Proc. Natl. Acad. Sci. USA 86. 15681571. 
[2] Margohs. B.. Rhee. S.G.. Fclder. S., Mrrvtc. M . Lyall, R , Lev- 
Itski. A.. Ullrtch. A., Ztlbrrstem. A. and Schlessmger. J. (1989) 
Cell 57. 1101~1107. 
[31 
[41 
[51 
161 
[71 
PI 
[91 
PO1 
[I 11 
[“I 
[I31 
[I41 
[I51 
[I61 
u71 
[I 81 
Metssnhelder, J . Suh. P.. Rhec. S.G and Hunter, T. (I 989) Cell 
57, I10991171 
Auger. K., Carpenter, C.L., Cantley. L C. and Varttcovskt, L 
(1989) J. BIoI. Chem 264. 20181~20184 
Varticovski. L.. Drukcr. B . Morrison. D . Cantlcy. L. and 
Roberts. T. (1989) Nature 331. 699--702 
Endemann. G 1 Yonezawa. K. and Roth. R.A. (1990) J. Biol. 
Chem 265. 396-100 
Cantley, L.C. Auger. K.R.. Carpenter. C.. Duckworth. B.. Gra- 
ztani. A.. Kapeller. R and Soltoff, S (1991) Cell 64. X-302 
Ghan. T.. Tanaka. A. BJorge. J D. and Fujna, D.J. (1990) Mol. 
Cell Biol. IO, 3180&3383. 
Morgan. D.O.. Kaplan. J M.. Bishop. J M and Varmus. H.E. 
( 1989) Cell 57. 7755786 
Cartwright. C.A.. Kamps. M P.. Meisler. A.I.. Pipas. J M. and 
E&hart, W (lY89) J. Clm Invest 83. 2025-2033. 
DeBrandebar, M , Geurns. G.. Naydcns. R.. Willebroords. R. 
and DeyMez. J. (1986) Cell Motel. Cytoskcleton 6, 11%113. 
Traynor-Kaplan. A.E . Harris, A L 1 Thompson. B.L.. Taylor, 
P. Omann. G M. and Shlar. L..4 ( 1989) J. BIoI. Chem 263, 
1566815673 
Walsh. J.P. Caldwell. K.K and MaJerus, P. (1991) Proc. Natl. 
Acad SC]. USA 88. 91849187. 
Seruman. LA. .4uger. K R Roberts. T.M. and Cantley. L.C. 
(1990) J. Vtrol. 64. 37184725 
Tsar. M.. Roudebush. M , Dobrowolakt. S 1 Yu. C.. Gibbs, J.B. 
and Stacey. D.W (19Y I ) Mol. Cell. Biol. I I, 2785-2793. 
Lassmg. 1. and Lmdberg. U (1985) Nature 314. 471474. 
Goldschmidt-Clermont. PJ 1 Machc-ky. L M., Baldaasare. J.J 
and Pollard. T.D. t IYYO) Scicncr 247. 157551578. 
Janmry. PA. and Stossel. T P (1987) Nature 325. 362-364. 
146 
